These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12170987)

  • 1. Marijuana safety study completed: weight gain, no safety problems.
    James JS
    AIDS Treat News; 2000 Aug; (348):3-4. PubMed ID: 12170987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical marijuana study in San Francisco: pays $1000, 25 days in hospital.
    AIDS Treat News; 1998 Jun; (No 296):3-4. PubMed ID: 11365468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marijuana withdrawal in humans: effects of oral THC or divalproex.
    Haney M; Hart CL; Vosburg SK; Nasser J; Bennett A; Zubaran C; Foltin RW
    Neuropsychopharmacology; 2004 Jan; 29(1):158-70. PubMed ID: 14560320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical marijuana: tribulations and trials.
    Abrams DI
    J Psychoactive Drugs; 1998; 30(2):163-9. PubMed ID: 9692378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical marijuana in HIV-positive patients: what do we know?
    Cinti S
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(6):342-6. PubMed ID: 19952287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical marijuana and dronabinol.
    PI Perspect; 1996 Nov; (No 20):20. PubMed ID: 11363969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HIV agents. Leading to lipodystrophy.
    TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312
    [No Abstract]   [Full Text] [Related]  

  • 8. Side effects. The usual suspects.
    TreatmentUpdate; 2002 Nov; 14(8):1-2. PubMed ID: 12501819
    [No Abstract]   [Full Text] [Related]  

  • 9. No nukes please.
    TreatmentUpdate; 2002 Nov; 14(8):6. PubMed ID: 12501825
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiretroviral drugs and the risk of myocardial infarction.
    Kaplan RC; Tien PC; Lazar J
    N Engl J Med; 2007 Aug; 357(7):715; author reply 716-7. PubMed ID: 17699825
    [No Abstract]   [Full Text] [Related]  

  • 11. Focus on fat.
    TreatmentUpdate; 2002 Nov; 14(8):4. PubMed ID: 12501822
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HIV drug update.
    Proj Inf Perspect; 2000 Aug; (30):5-6. PubMed ID: 12171015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.
    Staszewski S; Morales-Ramirez J; Tashima KT; Rachlis A; Skiest D; Stanford J; Stryker R; Johnson P; Labriola DF; Farina D; Manion DJ; Ruiz NM
    N Engl J Med; 1999 Dec; 341(25):1865-73. PubMed ID: 10601505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral drugs and the risk of myocardial infarction.
    Pollack TM; Rind DM
    N Engl J Med; 2007 Aug; 357(7):716; author reply 716-7. PubMed ID: 17703531
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipodystrophy--introduction.
    TreatmentUpdate; 2001; 13(7):2-3. PubMed ID: 11794857
    [No Abstract]   [Full Text] [Related]  

  • 17. New HIV guidelines offer adverse effects data.
    AIDS Alert; 2002 Jul; 17(7):89-91. PubMed ID: 12116974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicity profile of HAART.
    TreatmentUpdate; 2001; 13(7):6-7. PubMed ID: 11794864
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial.
    Perez-Molina JA; Rubio R; Rivero A; Pasquau J; Suárez-Lozano I; Riera M; Estébanez M; Santos J; Sanz-Moreno J; Troya J; Mariño A; Antela A; Navarro J; Esteban H; Moreno S;
    Lancet Infect Dis; 2015 Jul; 15(7):775-84. PubMed ID: 26062881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.